David D Gilbert, MD | |
350 N Wiget Ln Ste 200, Walnut Creek, CA 94598-2448 | |
(925) 934-7800 | |
Not Available |
Full Name | David D Gilbert |
---|---|
Gender | Male |
Speciality | Ophthalmology |
Experience | 23 Years |
Location | 350 N Wiget Ln Ste 200, Walnut Creek, California |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1033297536 | NPI | - | NPPES |
00A902020 | Medicaid | CA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207W00000X | Ophthalmology | A90202 (California) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
John Muir Medical Center - Walnut Creek Campus | Walnut creek, CA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
David D Gilbert Md Inc | 6103212907 | 5 |
News Archive
BioClinica, Inc., a global provider of clinical trial management services, today announced the release of BioClinica WebSend, a system that simplifies and accelerates image collection for clinical studies. WebSend transfers and tracks medical images in real-time, offering key benefits over the standard manual transport methods commonly used in imaging trials, including faster delivery of image data, enhanced data quality with fewer site queries, and reduced cost.
Stroke is the fourth-leading cause of death in the United States. Each year an estimated 795,000 people in this country experience a stroke. That's approximately the equivalent of every man, woman and child living in Anaheim and Long Beach combined.
Everyone knows that the best way to avoid the flu is by getting an annual flu shot. But a trip to your physician every autumn for the vaccination can help you avoid much more than the dreaded flu bug. "At the doctor's office, the focus is on you and what is going on with your health. This is your time to talk about concerns to improve your well-being beyond the flu season," says Jorge Parada, MD, MPH, the medical director of the Infection Prevention and Control Program at Loyola University Health System.
AB Science SA, a pharmaceutical company specialising in the research, development and commercialisation of protein kinase inhibitors (PKIs), announced today the recruitment of the first patient in the phase 3 study evaluating masitinib in severe persistent asthma.
Laboratories can now expand productivity levels using products designed to meet increasing demands for sustainability, cost-effectiveness and performance.
› Verified 8 days ago
Entity Name | David D Gilbert Md Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1780271908 PECOS PAC ID: 6103212907 Enrollment ID: O20220404001809 |
News Archive
BioClinica, Inc., a global provider of clinical trial management services, today announced the release of BioClinica WebSend, a system that simplifies and accelerates image collection for clinical studies. WebSend transfers and tracks medical images in real-time, offering key benefits over the standard manual transport methods commonly used in imaging trials, including faster delivery of image data, enhanced data quality with fewer site queries, and reduced cost.
Stroke is the fourth-leading cause of death in the United States. Each year an estimated 795,000 people in this country experience a stroke. That's approximately the equivalent of every man, woman and child living in Anaheim and Long Beach combined.
Everyone knows that the best way to avoid the flu is by getting an annual flu shot. But a trip to your physician every autumn for the vaccination can help you avoid much more than the dreaded flu bug. "At the doctor's office, the focus is on you and what is going on with your health. This is your time to talk about concerns to improve your well-being beyond the flu season," says Jorge Parada, MD, MPH, the medical director of the Infection Prevention and Control Program at Loyola University Health System.
AB Science SA, a pharmaceutical company specialising in the research, development and commercialisation of protein kinase inhibitors (PKIs), announced today the recruitment of the first patient in the phase 3 study evaluating masitinib in severe persistent asthma.
Laboratories can now expand productivity levels using products designed to meet increasing demands for sustainability, cost-effectiveness and performance.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
David D Gilbert, MD 350 N Wiget Ln Ste 200, Walnut Creek, CA 94598-2448 Ph: (925) 934-7800 | David D Gilbert, MD 350 N Wiget Ln Ste 200, Walnut Creek, CA 94598-2448 Ph: (925) 934-7800 |
News Archive
BioClinica, Inc., a global provider of clinical trial management services, today announced the release of BioClinica WebSend, a system that simplifies and accelerates image collection for clinical studies. WebSend transfers and tracks medical images in real-time, offering key benefits over the standard manual transport methods commonly used in imaging trials, including faster delivery of image data, enhanced data quality with fewer site queries, and reduced cost.
Stroke is the fourth-leading cause of death in the United States. Each year an estimated 795,000 people in this country experience a stroke. That's approximately the equivalent of every man, woman and child living in Anaheim and Long Beach combined.
Everyone knows that the best way to avoid the flu is by getting an annual flu shot. But a trip to your physician every autumn for the vaccination can help you avoid much more than the dreaded flu bug. "At the doctor's office, the focus is on you and what is going on with your health. This is your time to talk about concerns to improve your well-being beyond the flu season," says Jorge Parada, MD, MPH, the medical director of the Infection Prevention and Control Program at Loyola University Health System.
AB Science SA, a pharmaceutical company specialising in the research, development and commercialisation of protein kinase inhibitors (PKIs), announced today the recruitment of the first patient in the phase 3 study evaluating masitinib in severe persistent asthma.
Laboratories can now expand productivity levels using products designed to meet increasing demands for sustainability, cost-effectiveness and performance.
› Verified 8 days ago
Stephanie M. Po, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 320 Lennon Ln, Walnut Creek, CA 94598 Phone: 925-906-2000 | |
Joseph F Barakeh, DO PHD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1855 San Miguel Dr, #28, Walnut Creek, CA 94596 Phone: 925-935-4978 Fax: 925-935-9542 | |
Dr. Vahid Feiz, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 100 N Wiget Ln, Suite 270, Walnut Creek, CA 94598 Phone: 925-705-7299 Fax: 800-521-7886 | |
Mr. Allen Zachary Verne, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 122 La Casa Via, Suite #223, Walnut Creek, CA 94598 Phone: 925-943-6800 Fax: 925-943-6880 | |
Frances M. Dossetor, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 320 Lennon Ln, Walnut Creek, CA 94598 Phone: 925-906-2000 | |
Michelle T. Nee, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 320 Lennon Ln, Walnut Creek, CA 94598 Phone: 925-906-2000 |